deltatrials
Completed NA INTERVENTIONAL 2-arm NCT00868465

Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy (TRANSACT) (TRANSACT)

Sponsor: European Union

Conditions Uncomplicated Malaria
Interventions Artemether-Lumefantrine Dihydroartemisinin-piperaquine
Updated 6 times since 2017 Last updated: Jun 4, 2010 Started: Apr 30, 2009 Primary completion: May 31, 2010 Completion: May 31, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Uncomplicated Malaria, this trial is completed. The trial is conducted by European Union and has accumulated 6 data snapshots since 2009. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Mar 2022 · 14 months · monthly snapshotCompleted~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Mar 2022 — Jul 2024 [monthly]

    Completed NA

  4. Jan 2021 — Mar 2022 [monthly]

    Completed NA

  5. Jun 2018 — Jan 2021 [monthly]

    Completed NA

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Apr 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • European Union
  • Kilimanjaro Christian Medical Centre, Tanzania
  • Radboud University Medical Center
Data source: Radboud University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations